- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies, including Amgen and AstraZeneca, are adopting AI tools for clinical data gathering and drug development.
AstraZeneca partners with Modella AI to accelerate AI-driven clinical development.
1 report, 0 independent
Updated Jul 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AstraZeneca partners with Modella AI to accelerate AI-driven clinical development.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
- Geopolitical instability in the Middle East has led to significant corporate fallout, including the cancellation of Flutter's London Stock Exchange listing and AstraZeneca considering a move to the US market.
- AstraZeneca is relocating its registered office from Karnataka to Bengaluru, citing proximity to policy and financial ecosystems.
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet